<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7600053</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2780</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Lett</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Lett.</journal-id>
<journal-title-group>
<journal-title>Cancer letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">0304-3835</issn>
<issn pub-type="epub">1872-7980</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29154974</article-id>
<article-id pub-id-type="pmc">5743619</article-id>
<article-id pub-id-type="doi">10.1016/j.canlet.2017.11.011</article-id>
<article-id pub-id-type="manuscript">NIHMS921817</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prostate Cancer Health Disparities: An Immuno-biological Perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Sanjay</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Rajesh</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malik</surname>
<given-names>Shalie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manne</surname>
<given-names>Upender</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mishra</surname>
<given-names>Manoj</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Cancer Biology Research and Training Program, Department of Biological Sciences, Alabama State University, Montgomery, AL 36104</aff>
<aff id="A2">
<label>2</label>Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, 30310</aff>
<aff id="A3">
<label>3</label>Department of Zoology, University of Lucknow, Lucknow, India 226007</aff>
<aff id="A4">
<label>4</label>Department of Pathology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Address for Correspondence: Manoj K. Mishra, Cancer Biology Research and Training Program, Department of Biological Sciences, Alabama State University, Montgomery, AL 36104, USA; <email>mmishra@alasu.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p><bold>18. Conflict of interest:</bold> None</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>414</volume>
<fpage>153</fpage>
<lpage>165</lpage>
<!--elocation-id from pubmed: 10.1016/j.canlet.2017.11.011-->
<abstract>
<p id="P2">Prostate cancer (PCa) is the most commonly diagnosed malignancy in males, and, in the United States, is the second leading cause of cancer-related death for men older than 40 years. There is a higher incidence of PCa for African Americans (AAs) than for European-Americans (EAs). Investigations related to the incidence of PCa-related health disparities for AAs suggest that there are differences in the genetic makeup of these populations. Other differences are environmentally induced (e.g., diet and lifestyle), and the exposures are different. Men who immigrate from Eastern to Western countries have a higher risk of PCa than men in their native countries. However, the number of immigrants developing PCa is still lower than that of men in Western countries, suggesting that genetic factors are involved in the development of PCa. Altered genetic polymorphisms are associated with PCa progression. Androgens and the androgen receptor (AR) are involved in the development and progression of PCa. For populations with diverse racial/ethnic backgrounds, differences in lifestyle, diet, and biology, including genetic mutations/polymorphisms and levels of androgens and AR, are risk factors for PCa. Here, we provide an immune-biological perspective on PCa in relation to racial/ethnic disparities and identify factors associated with the disproportionate incidence of PCa and its clinical outcomes.</p>
</abstract>
<kwd-group>
<kwd>Health Disparity</kwd>
<kwd>Prostate Cancer</kwd>
<kwd>Immunotherapy</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>